Key September 2025 updates on U.S. healthcare funding, CDC leadership changes, AI in healthcare, Medicare and Medicaid policies, and COVID-19 vaccine authorization shifts impacting insurers and providers.
Reproductive Freedom for All and Planned Parenthood Action Fund oppose adding abortion restrictions to ACA premium tax credits amid ongoing healthcare affordability debates in Congress.
AdvaMed responds to CMS 2026 payment rule, stressing patient access to diabetes and prosthetic supplies amid competitive bidding concerns.
Explore how political donations and regulatory delays have impacted Medicare coverage and spending on costly skin substitute products lacking scientific validation.
The U.S. House advances legislation ensuring Medicare coverage for FDA-authorized breakthrough medical technologies, boosting patient access and streamlining approval processes.
Travelers Institute launches a multi-year initiative focused on insurance availability, affordability, and regulatory impacts in the US market. Key events and industry collaboration are planned.
AdvaMed raises patient safety and legal concerns over CMS's proposed Medicare competitive bidding programme restart for durable medical equipment and devices.
Overview of the 2025 federal healthcare regulatory agenda under the Trump administration, including Medicare rules, ACA integrity measures, and ongoing regulatory reviews impacting healthcare compliance and payer/provider operations.
NAHB advocates for insurance premium reductions for homes built to modern codes and resiliency standards like NGBS Green +RESILIENCE and IBHS FORTIFIED to address rising home insurance costs amid increasing natural disasters.
HHS plans to potentially remove members of the USPSTF, affecting preventive care coverage mandates under the Affordable Care Act and impacting insurance providers and patient access.
